We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
(+24%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
7.43%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$115M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$93.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$57.1M |
| 4 |
Eli Lilly
LLY
|
+$51.1M |
| 5 |
Qorvo
QRVO
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.5M |
| 3 |
Amazon
AMZN
|
+$65.6M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$58.8M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.9% |
| 2 | Technology | 32.83% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 3.92% |
| 5 | Consumer Discretionary | 3.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSPRU
51
DELISTED
Vesper Healthcare Acquisition Corp. Unit
VSPRU
| $24.2M | 0.64% |
2,000,000
| – | – |
|
52
Sensata Technologies
ST
$7.08B
| $22.8M | 0.6% |
432,519
+238,112
| +122% | +$11.4M |
|
|
OSH
53
DELISTED
Oak Street Health, Inc.
OSH
| $21.9M | 0.58% |
+358,250
| New | +$18.8M |
|
54
KLA
KLAC
$255B
| $21.8M | 0.58% |
843,210
-1,991,690
| -70% | -$46.4M |
|
55
Root
ROOT
$936M
| $21.8M | 0.58% |
+77,013
| New | +$25.4M |
|
56
Joby Aviation
JOBY
$7.84B
| $21.6M | 0.57% |
+1,866,684
| New | +$20.7M |
|
57
Synopsys
SNPS
$77.3B
| $20.4M | 0.54% |
+78,829
| New | +$18.2M |
|
58
Progyny
PGNY
$2.47B
| $20.3M | 0.54% |
+479,278
| New | +$15.6M |
|
59
Comcast
CMCSA
$88.5B
| $19.6M | 0.52% |
373,183
+171,846
| +85% | +$8.23M |
|
60
Monolithic Power Systems
MPWR
$65.6B
| $19.5M | 0.52% |
+53,328
| New | +$17.1M |
|
|
DOYU
61
DouYu International Holdings
DOYU
$143M
| $18.8M | 0.5% |
+169,569
| New | +$23M |
|
62
Ionis Pharmaceuticals
IONS
$9.15B
| $18.7M | 0.5% |
+331,377
| New | +$16.5M |
|
|
ONEM
63
DELISTED
1Life Healthcare
ONEM
| $18.6M | 0.49% |
426,394
-202,619
| -32% | -$6.92M |
|
64
Nerdy
NRDY
$107M
| $18.6M | 0.49% |
+1,676,298
| New | +$18.2M |
|
65
UnitedHealth
UNH
$370B
| $18.3M | 0.48% |
+52,061
| New | +$17.5M |
|
|
GLUU
66
DELISTED
Glu Mobile Inc.
GLUU
| $17.7M | 0.47% |
1,969,908
+996,785
| +102% | +$8.59M |
|
67
Netflix
NFLX
$306B
| $17.7M | 0.47% |
+326,970
| New | +$16.6M |
|
68
Maravai LifeSciences
MRVI
$948M
| $17.4M | 0.46% |
+619,217
| New | +$17.2M |
|
69
AbCellera Biologics
ABCL
$1.86B
| $17.3M | 0.46% |
+431,087
| New | +$19.7M |
|
70
T-Mobile US
TMUS
$190B
| $16.8M | 0.44% |
124,280
-190,852
| -61% | -$23.6M |
|
71
Praxis Precision Medicines
PRAX
$8.64B
| $16.6M | 0.44% |
+20,136
| New | +$11.8M |
|
|
DMYI.U
72
DELISTED
dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
DMYI.U
| $16.6M | 0.44% |
+1,456,000
| New | +$15.3M |
|
73
Illumina
ILMN
$30.7B
| $16.2M | 0.43% |
+45,135
| New | +$14.4M |
|
74
Omnicom Group
OMC
$22.4B
| $16.2M | 0.43% |
+260,234
| New | +$14.9M |
|
|
KDMN
75
DELISTED
Kadmon Holdings, Inc.
KDMN
| $16M | 0.42% |
3,849,843
-2,028,389
| -35% | -$8.01M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.
- Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
- Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
- Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
- Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
- Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
- Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
- Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.
Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.